Yaqing Zhang
Manage Your Profile
About
Dr. Zhang, Research Associate Professor, has been a pancreatic cancer researcher in the Department of Surgery at the University of Michigan since 2010. She joined the laboratory of Dr. Marina Pasca di Magliano as a post-doctoral fellow after receiving her PhD from the Fourth Military Medical University in China. She is also board-certified in Anatomic Pathology in China and has years of experience in surgical and forensic pathology. Dr. Zhang's research focuses on the mechanisms underlying the establishment of immune suppression in pancreatic cancer, with the goal of discovering novel immune-modulatory approaches to effectively treating pancreatic cancer.
Qualifications
-
Postdoctoral Research Fellow, Pancreatic CancerUniversity of Michigan Medical School, Ann Arbor, MI, United States
2010 - 2014
Postdoctoral Fellowship
-
Pathology ResidentQingdao Municipal Hospital, Department of Pathology, Qingdao, China
1997 - 2002
Residency
-
PhDFourth Military Medical University, Xi'an, China
2006 - 2010
-
MSQingdao University Medical College, Qingdao, China
2001 - 2003
-
MB BSQingdao University Medical College, Qingdao, China
1992 - 1997
Research Overview
Dr. Zhang's research interests include: 1) crosstalk between tumor cells and different types of stromal cells during both pancreatic cancer initiation and progression; 2) metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer; 3) targeting the immunosuppressive microenvironment as a therapeutic strategy in pancreatic cancer.
Recent Publications
-
Zhang Y, Kadiyala P, Yan W, Brown K, Avritt FR, Donahue KL, Procario MC, Okoye JO, Giridharan T, Elhossiny AM, Espinoza CE, Awad D, Lasse Opsahl EL, Medina-Cabrera PI, Velez-Delgado A, Menjivar RE, Yang OA, Yang S, He X, Gupta S, Tariq R, Brandt AR, Wang X, denDekker A, Nwosu ZC, Carpenter ES, Courtney AH, Bednar F, Frankel TL, Lyssiotis CA, Zheng B, Kryczek I, Pasca Di Magliano M. Cancer Immunol Res, 2026 Jun 2;Journal ArticleTargeting CCR1 remodels the tumor microenvironment and relieves immune suppression in pancreatic cancer.
DOI:10.1158/2326-6066.CIR-25-1300 -
Elhossiny AM, Kadiyala P, Okoye JO, Hiraki HL, Procario MC, Giridharan T, Watkoske HR, Tannus Ruckert M, Wang J, Griffith BD, Bray AW, Mills JN, Espinoza CE, Zeller J, Peterson N, Bednar F, Zhang Y, Rao A, Lyssiotis CA, Szczepanski JM, Shi J, Deshpande A, Maitra A, Fertig EJ, Carpenter ES, Frankel TL, Pasca di Magliano M. Cancer Discov, 2026 May 21;Journal ArticleAsynchronous evolution of epithelium and stroma differentiates precursor lesions from pancreatic cancer.
DOI:10.1158/2159-8290.CD-25-2001 PMID: 42165710 -
Ngodup T, Elson B, Mello AM, Hannifin S, Liu M, Zhang Y, Shi J, Shah YM, Lawrence DA, di Magliano MP, Lee KE. Science Advances, 2026 Apr 3; 12 (14):Journal ArticleA stromal PAI1-tPA axis orchestrates immunosuppression in pancreatic cancer
DOI:10.1126/sciadv.aea6734 PMID: 41931610 -
Bischoff AC, Brown K, Lasse Opsahl EL, Watkoske HR, Espinoza CE, Okoye JO, Olivei AC, Green LM, Rai R, The S, Yan W, denDekker AD, Carpenter ES, Shi J, Bednar F, Frankel TL, Zhang Y, Pasca di Magliano M. Cancer Research, 2026 Jan 16; 86 (2): 331 - 348.Journal ArticleWilms Tumor 1-Expressing Stromal Cells Promote Pancreatic Cancer Progression
DOI:10.1158/0008-5472.CAN-25-1014 PMID: 41032745 -
Griffith BD, Kadiyala P, McGue J, Sun L, Kumar A, Espinoza CE, Donahue KL, Iyer MK, Speyer C, Nelson S, Spiteri A, Elhossiny AM, Brown K, Attebury H, Bednar F, Carpenter ES, Kryczek I, Zhang Y, Zou W, Pasca di Magliano M, Frankel TL. Cancer Discov, 2026 Jan 12; 16 (1): 114 - 134.Journal ArticleAryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization.
DOI:10.1158/2159-8290.CD-25-0377 PMID: PMC12793834 -
Lasse Opsahl EL, Espinoza CE, Olivei AC, Okoye JO, Watkoske H, Hoffman MT, Avritt FR, Elhossiny AM, Bischoff AC, Donahue KL, Poggi M, Kadiyala P, Arya N, Shi J, Lee KE, Zhang Y, Carpenter ES, Szczepanski JM, Frankel TL, Pasca di Magliano M. Cancer Research, 2026 Jan 2; 86 (1): 22 - 39.Journal ArticleFibroblast STAT3 Activation Drives Organ-Specific Premetastatic Niche Formation
DOI:10.1158/0008-5472.CAN-25-3472 PMID: 41105672 -
Carpenter ES, Elhossiny AM, Kadiyala P, Li J, McGue J, Griffith BD, Zhang Y, Edwards J, Nelson S, Lima F, Donahue KL, Du W, Bischoff AC, Alomari D, Watkoske HR, Mattea M, The S, Espinoza CE, Barrett M, Sonnenday CJ, Olden N, Chen C-T, Peterson N, Gunchick V, Sahai V, Rao A, Bednar F, Shi J, Frankel TL, Pasca di Magliano M. 2025 Dec 11;Additional ScholarshipData from Analysis of Donor Pancreata Defines the Transcriptomic Signature and Microenvironment of Early Neoplastic Lesions
DOI:10.1158/2159-8290.c.6651113 -
Carpenter ES, Elhossiny AM, Kadiyala P, Li J, McGue J, Griffith BD, Zhang Y, Edwards J, Nelson S, Lima F, Donahue KL, Du W, Bischoff AC, Alomari D, Watkoske HR, Mattea M, The S, Espinoza CE, Barrett M, Sonnenday CJ, Olden N, Chen C-T, Peterson N, Gunchick V, Sahai V, Rao A, Bednar F, Shi J, Frankel TL, Pasca di Magliano M. 2025 Dec 11;Additional ScholarshipSupplementary Figures Part 1 from Analysis of Donor Pancreata Defines the Transcriptomic Signature and Microenvironment of Early Neoplastic Lesions
DOI:10.1158/2159-8290.30859329